MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
Country |
 USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NYSESPB |
Shares |
2.41 B |
Market Cap[1] |
$ 579 B |
EBITDA (LTM) |
$ 9.42 B |
P/E (LTM) |
23.59 |
P/S (LTM) |
6.25 |
EPS (LTM) |
10.13 |
Johnson & Johnson is a multinational corporation that specializes in healthcare products, medical devices, and pharmaceuticals. Founded in 1886, the company has grown to become one of the largest healthcare companies in the world, with operations in over 60 countries.
The company's products are used by millions of people every day, from baby shampoo and band-aids to prescription drugs and surgical equipment. Some of its most well-known brands include Tylenol, Neutrogena, and Listerine.
Johnson & Johnson is committed to improving the health and well-being of people around the world. The company invests heavily in research and development, with a focus on finding new treatments for diseases such as cancer, Alzheimer's, and HIV/AIDS.
In addition to its healthcare products, Johnson & Johnson is also known for its commitment to corporate social responsibility. The company has a long history of supporting various charitable causes, including disaster relief efforts and global health initiatives.
Overall, is a trusted and respected leader in the healthcare industry, with a strong track record of innovation and social responsibility.
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
AbCellera Biologics
ABCL
|
$ 3.44 | -4.32 % | $ 1.03 B | Nasdaq Global Select Market |  Canada |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Aptorum Group Limited
APM
|
$ 0.79 | -1.15 % | $ 4.31 M | Nasdaq Global Select Market |  China |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | China |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
ADMA Biologics
ADMA
|
$ 15.36 | -2.17 % | $ 3.66 B | Nasdaq Global Market | USA |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Apellis Pharmaceuticals
APLS
|
$ 20.28 | 0.65 % | $ 2.56 B | Nasdaq Global Select Market,SPB | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.51 | 1.35 % | $ 385 M | Nasdaq Global Select Market | Britain |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Anika Therapeutics
ANIK
|
$ 14.05 | -1.44 % | $ 206 M | Nasdaq Global Select Market,SPB | USA |
 |
ANI Pharmaceuticals
ANIP
|
$ 74.36 | -1.64 % | $ 1.44 B | Nasdaq Global Market,SPB | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
 |
Axsome Therapeutics
AXSM
|
$ 162.43 | 0.6 % | $ 8.08 B | Nasdaq Global Market,SPB | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 8.49 | -0.18 % | $ 1.75 B | Nasdaq Global Select Market | USA |
 |
BridgeBio Pharma
BBIO
|
$ 65.66 | -0.78 % | $ 12.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | Canada |
 |
Brainstorm Cell Therapeutics
BCLI
|
- | -2.5 % | $ 5.88 M | Nasdaq Capital Market | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
 |
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market |  Cayman-islands |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
- | -9.72 % | $ 5.89 M | Nasdaq Capital Market | USA |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
BioLineRx Ltd.
BLRX
|
$ 2.69 | -0.74 % | $ 908 M | Nasdaq Capital Market |  Israel |
 |
BioMarin Pharmaceutical
BMRN
|
$ 61.3 | 1.21 % | $ 11.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Burford Capital Limited
BUR
|
$ 7.79 | -5.75 % | $ 1.28 B | NYSE | Britain |
 |
CymaBay Therapeutics
CBAY
|
- | - | $ 3.45 B | Nasdaq Global Select Market | USA |
 |
Codexis
CDXS
|
$ 1.23 | -2.38 % | $ 90.3 M | Nasdaq Global Select Market | USA |
 |
Cabaletta Bio
CABA
|
$ 3.18 | -0.16 % | $ 3.71 M | Nasdaq Global Select Market | USA |
 |
Checkpoint Therapeutics
CKPT
|
- | - | $ 169 M | Nasdaq Capital Market | USA |
 |
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.